We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Cooperation Permits Quality of Analytical Examinations in Biomedical Research

The combination of specimen preparation with LMPC and the mature kit technology from Qiagen enables the user to analyze specimens far more specifically and efficiently.
News

Duke Researchers Uncover Genetic Link to Stroke After Heart Surgery

Patients with a specific combination of polymorphisms in genes responsible for the production of C-reactive protein (CRP) and interleukin-6 (IL-6) suffered stroke at three times higher rate.
News

Collaboration to Co-Market shRNA Target Validation Technology

RNAx provides Nucleis and its customers with in vitro shRNA validation technology to complement their proprietary transgenic animal generation technology, including the “Speedy Mouse® Technology” and vice versa.
News

Solexa and Collaborating Scientists Illuminate the Small RNA Component of the Transcriptome

This study generated two million short DNA sequences, known as signature sequences or sequence tags, to identify and quantify both known and novel small RNA molecules.
News

Applied Biosystems Announces Commercial Availability of TaqMan® MicroRNA Assays

TaqMan® miRNA Assays can be used to differentiate _expression levels of miRNA molecules during embryonic stem cell differentiation.
News

Agreement to License almaKnowledgeServer (AKS) as Part of Joint Research Project

Researchers based at EMBL headquarters will have access to the system as part of their daily research activities.
News

Patent Application for Biomarker-based Method to Diagnose Alzheimer's Disease

The patent application is being filed in conjunction with major research institutions in the Houston area, with Power3 having an exclusive license to commercialize the technology involved.
News

Bayer Selects InforSense for Next Generation Integrative Analytics Infrastructure

InforSense KDE, will provide Bayer with a flexible rapid application development platform to optimize their drug discovery decision-making.
News

Benitec Patents Upheld In Australia

Benitec Ltd.’s patents have been upheld to focus on developing RNA interference based therapeutics for the treatment of infectious diseases.
News

Hellsgate Vectors Simplifies the Use of HairpinRNAi

The Hellsgate vectors deliver double stranded hairpin RNA molecules corresponding to each selected gene, thereby destroying the messenger RNA for that gene and preventing its expression, silencing the gene.
Advertisement